Literature DB >> 9179763

Importance of sexual transmission of hepatitis C virus in seropositive pregnant women: a case-control study.

L Salleras1, M Bruguera, J Vidal, P Plans, A Domínguez, M Salleras, E Navas, N Galí.   

Abstract

The mode of hepatitis C virus (HCV) transmission in patients who deny parenteral exposure is still not understood. Seroprevalence studies of anti-HCV in sexually promiscuous populations and in spouses of infected patients have given contradictory results. We investigated the role of sexual transmission of HCV in a case-control study of risk factors for infection in a series of 43 anti-HCV positive pregnant women and 172 matched controls (4 for each case). In the univariate analysis, the following factors were associated significantly with anti-HCV seropositivity: low social class, unmarried, history of abortion, wounds which were sutured, tattooes, sharing toiletries with the partner, sexual contact outside the partnership without condom use, blood transfusion, and intravenous drug abuse, but only the last 3 factors remained significantly associated with HCV infection in multiple logistic regression analysis. The relative risk of HCV infection increased according to the increased number of sexual partners. Thus sexual transmission must be considered a possible mode of infection in HCV infected persons without parenteral exposures.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179763     DOI: 10.1002/(sici)1096-9071(199706)52:2<164::aid-jmv8>3.0.co;2-1

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

Review 1.  Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals.

Authors:  Susanna Naggie; Mark S Sulkowski
Journal:  Gastroenterology       Date:  2012-05       Impact factor: 22.682

Review 2.  Screening in liver disease.

Authors:  Paolo Del Poggio; Marzio Mazzoleni
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

3.  Measures to reduce HIV infection have not been successful to reduce the prevalence of HCV in intravenous drug users.

Authors:  I Hernandez-Aguado; J M Ramos-Rincon; M J Aviñio; J Gonzalez-Aracil; S Pérez-Hoyos; M G de la Hera
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 4.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

5.  Factors associated with prevalent hepatitis C infection among HIV-infected women with no reported history of injection drug use: the Women's Interagency HIV Study (WIHS).

Authors:  Toni Frederick; Pamela Burian; Norah Terrault; Mardge Cohen; Michael Augenbraun; Mary Young; Eric Seaberg; Jessica Justman; Alexandra M Levine; Wendy J Mack; Andrea Kovacs
Journal:  AIDS Patient Care STDS       Date:  2009-11       Impact factor: 5.078

6.  Risk factors for hepatitis C infection among sexually transmitted disease-infected, inner city obstetric patients.

Authors:  Youyin Choy; Lisa Gittens-Williams; Joseph Apuzzio; Joan Skurnick; Carl Zollicoffer; Peter G McGovern
Journal:  Infect Dis Obstet Gynecol       Date:  2003
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.